NAV — Navco Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual balance sheet for Navco Pharmaceuticals, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.

	2022 June 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—
Source:	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.235	0.007	0.003
Net Total Accounts Receivable
Net Total Receivables	0.11	0.046	0.066	0
Total Inventory
Prepaid Expenses
Total Current Assets	0.112	0.711	0.074	0.003
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.184	0.001	0
Net Intangible Assets
Total Assets	0.112	0.932	0.075	0.003
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.109	0.753	0.932	0.939
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.109	0.844	0.932	0.939
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	0.003	0.087	-0.857	-0.936
Total Liabilities & Shareholders' Equity	0.112	0.932	0.075	0.003
Total Common Shares Outstanding